Skip to main content
Amoy Diagnostics Co.,Ltd. logo

Amoy Diagnostics Co.,Ltd. — Investor Relations & Filings

Ticker · 300685 ISIN · CNE1000034D3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,088 across all filing types
Latest filing 2023-02-12 AGM Information
Country CN China
Listing Shenzhen Stock Exchange 300685

About Amoy Diagnostics Co.,Ltd.

https://www.amoydx.com

Amoy Diagnostics Co., Ltd. specializes in the development and commercialization of molecular diagnostic products for precision oncology. The company provides a comprehensive portfolio of testing kits designed to identify genetic mutations and biomarkers essential for personalized cancer treatment. Its core technology platforms include the proprietary ADx-ARMS, Super-ARMS, and specialized Next-Generation Sequencing (NGS) solutions. AmoyDx focuses on companion diagnostics (CDx), collaborating extensively with global pharmaceutical companies to integrate diagnostic testing into clinical drug development and patient management. Key products cover a wide range of solid tumors, including lung, colorectal, and breast cancers, facilitating targeted therapy selection and monitoring. The company maintains rigorous quality standards, with numerous products receiving regulatory approvals for clinical use in multiple international markets.

Recent filings

Filing Released Lang Actions
关于召开2023年第一次临时股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about convening the 2023 first extraordinary general meeting of shareholders for a company, including meeting details, voting procedures, registration methods, and agenda items. It does not contain financial statements or results but rather logistical and procedural information about the shareholders' meeting. It is not an annual or interim report, earnings release, or any financial report. It is not a voting results announcement since it is a notice before the meeting. The document fits the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings. The document length is under 5,000 characters, but it is not merely an announcement of a report publication; it is the actual meeting notice and related materials. Therefore, the correct classification is AGM Information (AGM-R).
2023-02-12 Chinese
公司章程（2023年2月）
Governance Information Classification · 100% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of 厦门艾德生物医药科技股份有限公司 dated February 2023. It contains detailed provisions about the company's organizational structure, shareholder rights, board of directors, management, share issuance, share transfer, shareholder meetings, and other governance-related rules. It is a comprehensive governance document that sets out the internal rules and regulations of the company. There is no indication that this is an announcement, a financial report, or a meeting transcript. The content aligns with the definition of Governance Information (CGR), which covers the company's internal rules, board structure, and governance practices.
2023-02-12 Chinese
第三届董事会第九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the company's third board of directors' ninth meeting. It details the election of a non-independent director, changes in registered capital and amendments to the company bylaws, and the scheduling of an extraordinary shareholders' meeting. The content focuses on board decisions and governance matters rather than financial results or reports. It is not a full annual or interim report, nor an earnings release or audit report. It is not a proxy solicitation or voting results announcement. The document is a board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is short and it contains detailed board decisions, not just a notice or report publication announcement. Therefore, the classification is MANG with high confidence.
2023-02-12 Chinese
独立董事关于相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors regarding the nomination and qualifications of a non-independent director candidate for the company's board. It references compliance with company bylaws and relevant laws, and it is related to board composition and governance matters. There is no financial data, no report publication, no voting results, and no mention of financial performance or regulatory filings. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2023-02-12 Chinese
关于5%以上股东拟进行大宗交易的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding a shareholder holding more than 5% of the company's shares planning to reduce their holdings through block trades. It details the shareholder's identity, the number and percentage of shares held, the planned reduction amount, timing, and commitments related to the share reduction. There are no financial statements, earnings data, or management discussion of results. The document is a formal disclosure of a major shareholding change and planned transaction by a significant shareholder. This fits the definition of a Major Shareholding Notification (MRQ). The document length is 2460 characters, which is typical for such announcements and not a full report or regulatory filing. Therefore, the correct classification is MRQ with high confidence.
2023-02-07 Chinese
关于回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase plan. It details the number of shares repurchased, the price range, total amount spent, compliance with regulatory guidelines, and timing restrictions for repurchases. It does not contain financial statements or comprehensive financial data but rather updates on the status of the share buyback program. The document length is short (1320 characters) and focuses on the repurchase activity itself, not a report or announcement of a report publication. Therefore, it fits the category of Transaction in Own Shares (POS).
2023-02-02 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.